{"count": 268, "results": [{"_id": "33287831", "pmid": 33287831, "pmcid": "PMC7720571", "title": "Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis", "journal": "J Nanobiotechnology", "authors": ["Mu D", "Li J", "Qi Y", "Sun X", "Liu Y", "Shen S", "Li Y", "Xu B", "Zhang B"], "date": "2020-12-07T00:00:00Z", "doi": "10.1186/s12951-020-00744-w", "meta_date_publication": "2020 Dec 7", "meta_volume": "18", "meta_issue": "1", "meta_pages": "179", "score": 50283.055, "text_hl": "In conclusion, the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@-loaded micelle system provides a promising and innovative option against @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@.", "citations": {"NLM": "Mu D, Li J, Qi Y, Sun X, Liu Y, Shen S, Li Y, Xu B, Zhang B. Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis J Nanobiotechnology. 2020 Dec 7;18(1):179. PMID: 33287831", "BibTeX": "@article{33287831, title={Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis}, author={Mu D and Li J and Qi Y and Sun X and Liu Y and Shen S and Li Y and Xu B and Zhang B}, journal={J Nanobiotechnology}, volume={18}, number={1}, pages={179}}"}}, {"_id": "36970211", "pmid": 36970211, "pmcid": "PMC10031343", "title": "Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms", "journal": "Acta Pharm Sin B", "authors": ["Yang Y", "Feng K", "Yuan L", "Liu Y", "Zhang M", "Guo K", "Yin Z", "Wang W", "Zhou S", "Sun H", "Yan K", "Yan X", "Wang X", "Duan Y", "Hu Y", "Han J"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.apsb.2022.11.012", "meta_date_publication": "2023 Mar", "meta_volume": "13", "meta_issue": "3", "meta_pages": "1036-1052", "score": 50276.355, "text_hl": "Taken together, our study suggests that CDDP or CDDP plus a low dose of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ can be an effective therapy to reduce @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@/@<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@-induced @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@.", "citations": {"NLM": "Yang Y, Feng K, Yuan L, Liu Y, Zhang M, Guo K, Yin Z, Wang W, Zhou S, Sun H, Yan K, Yan X, Wang X, Duan Y, Hu Y, Han J. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms Acta Pharm Sin B. 2023 Mar;13(3):1036-1052. PMID: 36970211", "BibTeX": "@article{36970211, title={Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms}, author={Yang Y and Feng K and Yuan L and Liu Y and Zhang M and Guo K and Yin Z and Wang W and Zhou S and Sun H and Yan K and Yan X and Wang X and Duan Y and Hu Y and Han J}, journal={Acta Pharm Sin B}, volume={13}, number={3}, pages={1036-1052}}"}}, {"_id": "40801072", "pmid": 40801072, "title": "In the wake of the Scandinavian Simvastatin Survival Study trial.", "journal": "Curr Opin Lipidol", "authors": ["Strandberg TE"], "date": "2025-08-08T00:00:00Z", "doi": "10.1097/MOL.0000000000001008", "meta_date_publication": "2025 Aug 8", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50269.266, "text_hl": "PURPOSE OF REVIEW: In 1994, the 4S trial was revolutionary by showing that @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ lowering with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduced, not only @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic vascular disease@@@ (@<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@ASCVD@@@) events, but also all-cause mortality as compared to placebo. ", "citations": {"NLM": "Strandberg TE. In the wake of the Scandinavian Simvastatin Survival Study trial. Curr Opin Lipidol. 2025 Aug 8;():. PMID: 40801072", "BibTeX": "@article{40801072, title={In the wake of the Scandinavian Simvastatin Survival Study trial.}, author={Strandberg TE}, journal={Curr Opin Lipidol}}"}}, {"_id": "35745836", "pmid": 35745836, "pmcid": "PMC9227583", "title": "Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis", "journal": "Pharmaceutics", "authors": ["Song K", "Tang Z", "Song Z", "Meng S", "Yang X", "Guo H", "Zhu Y", "Wang X"], "date": "2022-06-14T00:00:00Z", "doi": "10.3390/pharmaceutics14061265", "meta_date_publication": "2022 Jun 14", "meta_volume": "14", "meta_issue": "6", "meta_pages": "", "score": 50267.4, "text_hl": "@CHEMICAL_Hyaluronic_Acid @CHEMICAL_MESH:D006820 @@@Hyaluronic Acid@@@-Functionalized Mesoporous @CHEMICAL_Silicon_Dioxide @CHEMICAL_MESH:D012822 @@@Silica@@@ Nanoparticles Loading @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ for Targeted Therapy of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@Atherosclerosis@@@", "citations": {"NLM": "Song K, Tang Z, Song Z, Meng S, Yang X, Guo H, Zhu Y, Wang X. Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis Pharmaceutics. 2022 Jun 14;14(6):. PMID: 35745836", "BibTeX": "@article{35745836, title={Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis}, author={Song K and Tang Z and Song Z and Meng S and Yang X and Guo H and Zhu Y and Wang X}, journal={Pharmaceutics}, volume={14}, number={6}}"}}, {"_id": "33711324", "pmid": 33711324, "pmcid": "PMC8063863", "title": "Simvastatin inhibits POVPC-mediated induction of endothelial-to-mesenchymal cell transition", "journal": "J Lipid Res", "authors": ["Li Y", "Zhang YX", "Ning DS", "Chen J", "Li SX", "Mo ZW", "Peng YM", "He SH", "Chen YT", "Zheng CJ", "Gao JJ", "Yuan HX", "Ou JS", "Ou ZJ"], "date": "2021-01-01T00:00:00Z", "doi": "10.1016/j.jlr.2021.100066", "meta_date_publication": "2021", "meta_volume": "62", "meta_issue": "", "meta_pages": "100066", "score": 50264.594, "text_hl": "Our findings reveal a novel mechanism of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@ that can be inhibited by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Li Y, Zhang YX, Ning DS, Chen J, Li SX, Mo ZW, Peng YM, He SH, Chen YT, Zheng CJ, Gao JJ, Yuan HX, Ou JS, Ou ZJ. Simvastatin inhibits POVPC-mediated induction of endothelial-to-mesenchymal cell transition J Lipid Res. 2021;62():100066. PMID: 33711324", "BibTeX": "@article{33711324, title={Simvastatin inhibits POVPC-mediated induction of endothelial-to-mesenchymal cell transition}, author={Li Y and Zhang YX and Ning DS and Chen J and Li SX and Mo ZW and Peng YM and He SH and Chen YT and Zheng CJ and Gao JJ and Yuan HX and Ou JS and Ou ZJ}, journal={J Lipid Res}, volume={62}, pages={100066}}"}}, {"_id": "35858474", "pmid": 35858474, "title": "pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.", "journal": "Biomater Sci", "authors": ["Obaid EAMS", "Wu S", "Zhong Y", "Yan M", "Zhu L", "Li B", "Wang Y", "Wu W", "Wang G"], "date": "2022-08-24T00:00:00Z", "doi": "10.1039/d2bm00603k", "meta_date_publication": "2022 Aug 24", "meta_volume": "10", "meta_issue": "17", "meta_pages": "4837-4847", "score": 50262.777, "text_hl": "Herein, we employed a one-step self-assembly approach for effectively encapsulating the anti-AS drug @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@) in zeolitic imidazolate framework-8 (ZIF-8) (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@/ZIF-8), and then coated it with @CHEMICAL_Hyaluronic_Acid @CHEMICAL_MESH:D006820 @@@hyaluronic acid@@@ (@CHEMICAL_Hyaluronic_Acid @CHEMICAL_MESH:D006820 @@@HA@@@) to fabricate the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@/ZIF-8@HA nanoplatform. ", "citations": {"NLM": "Obaid EAMS, Wu S, Zhong Y, Yan M, Zhu L, Li B, Wang Y, Wu W, Wang G. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy. Biomater Sci. 2022 Aug 24;10(17):4837-4847. PMID: 35858474", "BibTeX": "@article{35858474, title={pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.}, author={Obaid EAMS and Wu S and Zhong Y and Yan M and Zhu L and Li B and Wang Y and Wu W and Wang G}, journal={Biomater Sci}, volume={10}, number={17}, pages={4837-4847}}"}}, {"_id": "34587943", "pmid": 34587943, "pmcid": "PMC8482657", "title": "Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction", "journal": "Lipids Health Dis", "authors": ["Pinto LCS", "Mello APQ", "Izar MCO", "Damasceno NRT", "Neto AMF", "França CN", "Caixeta A", "Bianco HT", "Póvoa RMS", "Moreira FT", "Bacchin ASF", "Fonseca FA"], "date": "2021-09-29T00:00:00Z", "doi": "10.1186/s12944-021-01559-w", "meta_date_publication": "2021 Sep 29", "meta_volume": "20", "meta_issue": "1", "meta_pages": "124", "score": 50260.62, "text_hl": "Higher effectiveness in the clearance of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherogenic IDL@@@ particles was also observed following @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ plus @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ therapy compared with @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ monotherapy", "citations": {"NLM": "Pinto LCS, Mello APQ, Izar MCO, Damasceno NRT, Neto AMF, França CN, Caixeta A, Bianco HT, Póvoa RMS, Moreira FT, Bacchin ASF, Fonseca FA. Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction Lipids Health Dis. 2021 Sep 29;20(1):124. PMID: 34587943", "BibTeX": "@article{34587943, title={Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction}, author={Pinto LCS and Mello APQ and Izar MCO and Damasceno NRT and Neto AMF and França CN and Caixeta A and Bianco HT and Póvoa RMS and Moreira FT and Bacchin ASF and Fonseca FA}, journal={Lipids Health Dis}, volume={20}, number={1}, pages={124}}"}}, {"_id": "32334199", "pmid": 32334199, "title": "A self-driven bioinspired nanovehicle by leukocyte membrane-hitchhiking for early detection and treatment of atherosclerosis.", "journal": "Biomaterials", "authors": ["Wu G", "Wei W", "Zhang J", "Nie W", "Yuan L", "Huang Y", "Zuo L", "Huang L", "Xi X", "Xie HY"], "date": "2020-08-01T00:00:00Z", "doi": "10.1016/j.biomaterials.2020.119963", "meta_date_publication": "2020 Aug", "meta_volume": "250", "meta_issue": "", "meta_pages": "119963", "score": 50258.945, "text_hl": "Upon sequentially embedding an anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ drug @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@ST@@@) and decorating a targetable @GENE_APOA1 @GENE_335 @@@apolipoprotein A-I@@@ mimetic 4F peptide (AP), the as-fabricated MNC@M@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@-ST@@@/AP exhibits excellent anti-@<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic@@@ effects by alleviating @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and oxidative stress as well as promoting @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ efflux via RCT pathways. ", "citations": {"NLM": "Wu G, Wei W, Zhang J, Nie W, Yuan L, Huang Y, Zuo L, Huang L, Xi X, Xie HY. A self-driven bioinspired nanovehicle by leukocyte membrane-hitchhiking for early detection and treatment of atherosclerosis. Biomaterials. 2020 Aug;250():119963. PMID: 32334199", "BibTeX": "@article{32334199, title={A self-driven bioinspired nanovehicle by leukocyte membrane-hitchhiking for early detection and treatment of atherosclerosis.}, author={Wu G and Wei W and Zhang J and Nie W and Yuan L and Huang Y and Zuo L and Huang L and Xi X and Xie HY}, journal={Biomaterials}, volume={250}, pages={119963}}"}}, {"_id": "40050920", "pmid": 40050920, "title": "ROS-responsive simvastatin nano-prodrug based on tertiary amine-oxide zwitterionic polymer for atherosclerotic therapy.", "journal": "J Nanobiotechnology", "authors": ["Yang H", "Guo M", "Guan Q", "Zhang L", "Liu M", "Li H", "Qiao G", "Yang Q", "Shen M", "Li Y"], "date": "2025-03-06T00:00:00Z", "doi": "10.1186/s12951-025-03232-1", "meta_date_publication": "2025 Mar 6", "meta_volume": "23", "meta_issue": "1", "meta_pages": "176", "score": 50258.258, "text_hl": "@CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@ROS@@@-responsive @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ nano-prodrug based on tertiary amine-oxide zwitterionic polymer for @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic@@@ therapy.", "citations": {"NLM": "Yang H, Guo M, Guan Q, Zhang L, Liu M, Li H, Qiao G, Yang Q, Shen M, Li Y. ROS-responsive simvastatin nano-prodrug based on tertiary amine-oxide zwitterionic polymer for atherosclerotic therapy. J Nanobiotechnology. 2025 Mar 6;23(1):176. PMID: 40050920", "BibTeX": "@article{40050920, title={ROS-responsive simvastatin nano-prodrug based on tertiary amine-oxide zwitterionic polymer for atherosclerotic therapy.}, author={Yang H and Guo M and Guan Q and Zhang L and Liu M and Li H and Qiao G and Yang Q and Shen M and Li Y}, journal={J Nanobiotechnology}, volume={23}, number={1}, pages={176}}"}}, {"_id": "33859959", "pmid": 33859959, "pmcid": "PMC8027052", "title": "Ethereal Extract of Pepper: Preventing Atherosclerosis and Left Ventricle Remodeling in LDL Receptor Knockout Mice", "journal": "Prev Nutr Food Sci", "authors": ["Dos Santos L", "Maciel LO", "Gracia EKI", "Soares EA", "Sarto DAQS", "Barauna VG", "Estrela HFG", "Rocha CM", "Carvalho MDGS", "Boas BMV", "Garcia JAD"], "date": "2021-03-31T00:00:00Z", "doi": "10.3746/pnf.2021.26.1.51", "meta_date_publication": "2021 Mar 31", "meta_volume": "26", "meta_issue": "1", "meta_pages": "51-57", "score": 50257.55, "text_hl": "After 60 days, treatment with both red pepper ethereal extracts and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ prevented @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@, @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic lesion@@@ progression, and @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricle hypertrophy@@@. ", "citations": {"NLM": "Dos Santos L, Maciel LO, Gracia EKI, Soares EA, Sarto DAQS, Barauna VG, Estrela HFG, Rocha CM, Carvalho MDGS, Boas BMV, Garcia JAD. Ethereal Extract of Pepper: Preventing Atherosclerosis and Left Ventricle Remodeling in LDL Receptor Knockout Mice Prev Nutr Food Sci. 2021 Mar 31;26(1):51-57. PMID: 33859959", "BibTeX": "@article{33859959, title={Ethereal Extract of Pepper: Preventing Atherosclerosis and Left Ventricle Remodeling in LDL Receptor Knockout Mice}, author={Dos Santos L and Maciel LO and Gracia EKI and Soares EA and Sarto DAQS and Barauna VG and Estrela HFG and Rocha CM and Carvalho MDGS and Boas BMV and Garcia JAD}, journal={Prev Nutr Food Sci}, volume={26}, number={1}, pages={51-57}}"}}]}